Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis

Blood

Volumn 90, Issue 3, 1997, Pages 958-966

  Schuster, Volker ^a   Mingers, Anne Marie ^b   Seidenspinner, Silvia ^b   Nüssgens, Zita ^b   Pukrop, Tanja ^b   Kreth, Hans Wolfgang ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN;

ADOLESCENT; ARTICLE; CASE REPORT; CONJUNCTIVITIS; FEMALE; GENE MUTATION; HUMAN; HYDROCEPHALUS; MUCOSA; PRIORITY JOURNAL; TURKEY (REPUBLIC);

EID: 0030739571     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.958     Document Type: Article

References (52)

1. Bouisson M: Ophthalmie sur-aigue avec formation de pseudomembranes à la surface de la conjonctive. Ann Oculist 17:100, 1847
2. Borel MG: Un nouvau syndrome palpébral. Bull Soc Franç Ophthalm46:168, 1933
3. Cohen SR: Ligneous conjunctivitis: An ophthalmic disease with potentially fatal tracheobronchial obstruction. Laryngeal and tracheobronchial features. Ann Otol Rhinol Laryngol 99:509, 1990
4. Cooper TJ, Kazdan JJ, Cutz E: Ligneous conjunctivitis with tracheal obstruction. A case report with light and electron microscopy findings. Can J Ophthalmol 14:57, 1979
5. Newcomer V, Klein A: Ligneous conjunctivitis. Arch Dermatol 113:511, 1977
6. Rubin A, Buck D, Macdonald MR: Ligneous conjunctivitis involving the cervix. Case report. Br J Obstet Gynaecol 96:1228, 1989
7. Scurry J, Planner R, Fortune DW, Lee CS, Rode J: Ligneous (pseudomembranous) inflammation of the female genital tract. A report of two cases. J Reprod Med 38:407, 1993
8. Holland E, Chan C-C, Kuwabara T, Palestine AG, Rowsey JJ, Nussenblatt RB: Immunohistological findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol 107:160, 1989
9. Chambers JD, Blodi FC, Golden B, McKee AP: Ligneous conjunctivitis. Trans Am Acad Ophthalmol Otolaryngol 73:996, 1969
10. Eagle R, Brooks JSJ, Katowitz JA, Weinberg JC, Perry HD: Fibrin as a major constituent of ligneous conjunctivitis. Am J Ophthalmol 101:493, 1986
11. De Cock R, Ficker LA, Dart JG, Garner A, Wright V: Topical heparin in the treatment of ligneous conjunctivitis. Ophthalmology 102:1654, 1995
12. Pfannkuch F, Schmidt R, Schmidt B, Seiler TH: Morphologische Untersuchungen zur Pathogenese der Conjunctivitis lignosa. Klin Monatsbl Augenheilkd 190:40, 1987
13. Bateman JB, Pettit TH, Isenberg SJ, Simons KB: Ligneous conjunctivitis: An autosomal recessive disorder. J Pediatr Ophtalmol Strabismus 23:137, 1986
14. Goldman H, Hof W: Familiäre pseudomembranöse Conjunctivitis. Schweiz Med Wochenschr 84:73, 1954
15. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V: Homozygous type I plasminogen deficiency: Ligneous conjunctivitis and additional lesions in other mucous membranes as important clinical manifestations. Semin Thromb Hemost (in press)
16. Nüssgens Z, Roggenkämper P: Ligneous conjunctivitis. Ten years follow up. Ophthalmic Paediatr Genet 14:137, 1993
17. Parunovic A, Stefanovic D: Ligneous conjunctivitis and hydrocephalus: An unusual association. Vestnic Oftalmologii 109:30, 1993
18. Berlin AJ, Carim M, Langston RH, Price RL: Scierai grafting in the management of ligneous conjunctivitis. Ophthalmic Surg 13:288, 1982
19. Ramsey DT, Ketring KL, Glaze MB, Knight B, Render JA: Ligneous conjunctivitis in four Doberman pinschers. J Am Anim Hosp Assoc 32:439, 1996
20. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45, 1966
21. Petersen TE, Martzen MR, Ichinose A, Davie EW: Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 265:6104, 1990
22. 572 to Pro mutation. Blood 82:475, 1993
23. Schuster V, Seidenspinner S, Kreth HW: Detection of a novel mutation in the Src homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia. Am J Med Genet 63:318, 1996
24. Azuma H, Mima N, Shirakawa M, Miyamoto K, Yamaguchi H, Mitsui T, Shigekiyo T, Shigekiyo T, Saito S: Molecular pathogenesis of type I congenital plasminogen deficiency: Expression of recombinant human mutant plasminogens in mammalian cells. Blood 89:183, 1997
25. Schäfer BM, Maier K, Eickhoff U, Todd RF, Kramer MD: Plasminogen activation in healing human wounds. Am J Pathol 144:1269, 1994
26. Schäfer BM, Maier K, Eickhoff U, Bechtel M, Kramer MD: Alpha(2)-antiplasmin and plasminogen activator inhibitors in healing skin wounds. Arch Dermatol Res 288:122, 1996
27. Salonen EM, Lauharanta J, Sim PS, Stephens R, Vaheri A: Rapid appearance of plasmin in tear fluid after ocular allergen exposure. Clin Exp Immunol 73:146, 1988
28. Tervo T, Honkanen N, van Setten GB, Virtanen T, Tarkkanen A, Harkonen M: A rapid fluorometric assay for tear fluid plasmin activity. Cornea 13:148, 1994
29. Firat T: Ligneous conjunctivitis. Am J Ophthalmol 78:679, 1974
30. Hidayat HM, Riddle PJ: Ligneous conjunctivitis: A clinico-pathologic study of 17 cases. Ophthalmology 94:949, 1987
31. Weinstock SM, Kielar RA: Bulbar ligneous conjunctivitis after pterygium removal in an elderly man. Am J Ophthalmol 79:913, 1975
32. Girard LJ, Veselinovic A, Ront RL: Ligneous conjunctivitis after pinguecula removal in an adult. Cornea 8:7, 1989
33. Schwartz GS, Holland EJ: Induction of ligneous conjunctivitis by conjunctival surgery. Am J Ophthalmol 120:253, 1995
34. Diamond JP, Chandna A, Williams C, Easty DL, Scully C, Eveson J, Richards A: Tranexamic acid-associated ligneous conjunctivitis with gingival and peritoneal lesions. Br J Ophthalmol 75:753, 1991
35. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL: The cell biology of the plasminogen system. FASEB J 9:939, 1995
36. Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S: Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 67:189, 1992
37. Tait RC, Walker ID, Conkie JA, Islam SI. McCall F: Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 76:1004, 1996
38. Machovich R, Owen WG: The elastase-mediated pathway of fibrinolysis. Blood Coagul Fibrinolysis 1:79, 1990
39. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J: Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD1 1b/CD18): A nonplasmin fibrinolytic pathway. Blood 82:2414, 1993
40. 675 substitution. Thromb Haemost 75:96, 1996
41. Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW: Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 88:115, 1991
42. Kikuchi S, Yamanouchi Y, Li L, Kobayashi, Ijima H, Miyazaki R, Tsuchiya S, Hamaguchi H: Plasminogen with type-I mutation is polymorphic in the Japanese population. Hum Genet 90:7, 1992
43. Li L, Kikuchi S, Arinami T, Kobayashi K, Tsuchiya S, Hamaguchi H: Plasminogen with type-I mutation in the Chinese Han population. Clin Genet 45:285, 1994
44. Ploplis VA, Carmeliet P, Vazirzadeh S, Vanvlaenderen I, Moons L, Plow EF, Collen D: Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92:2585, 1995
45. Bugge TH, Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794, 1995
46. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL: Loss of fibrinogen rescues mice from pleiotropic effects of plasminogen deficiency. Cell 87:709, 1996
47. Rømer J, Bugge TH, Pyke C, Lund LR, Flick M, Degen J, Danø K: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287, 1996
48. Carmeliet P, Moons L, Ploplis V, Plow E, Collen D: Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200, 1997
49. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185:963, 1997
50. Bugge TH, Flick MJ, Danton MJ, Daugherty C, Rømer J, Danø K, Carmeliet P, Collen D, Degen JL: Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899, 1996
51. Lijnen HR, Carmeliet P, Bouché A, Moons L, Ploplis VA, Plow EF, Collen D: Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen. Blood 88:870, 1996
52. Forsgren M, Raden B, Israelsson M, Larsson K, Hedén L-O: Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett 213:254, 1987